Please ensure Javascript is enabled for purposes of website accessibility

Why Viacom, Ferroglobe, and Biogen Jumped Today

By Dan Caplinger - Updated Apr 16, 2019 at 8:09AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out what these three stocks have in common.

The stock market rebounded somewhat on Tuesday, although major benchmarks finished with gains that were far smaller than what they'd been earlier in the session. Investors are trying to get past the ominous warning that an inverted yield curve has made regarding a possible future slowdown of the U.S. economy, but early gains of more than 1% eroded as market participants considered some of the macroeconomic and geopolitical risks affecting the financial markets more broadly. Even with the up-and-down motion of the broader indexes, some stocks enjoyed significant advances. Viacom (NASDAQ: VIA) (VIAB), Ferroglobe (GSM 3.01%), and Biogen (BIIB 1.27%) were among the top performers. Here's why they did so well.

Could Viacom and CBS merge after all?

Shares of Viacom rose over 7% after reports that the media giant is apparently back in talks with network company CBS (PARA 1.51%) to merge. Viacom made news yesterday when it negotiated a renewed agreement with AT&T that resolved what could have become a sticky situation with video subscribers, and some believe that the agreement might have made it possible for CBS and Viacom to consider a combination more seriously. The two companies have been no strangers to past merger speculation, but even without guarantees that any deal will eventually get done, Viacom shareholders seem pleased at the idea.

Viacom international studio building with five movie posters and a partly cloudy sky above.

Image source: Viacom.

Ferroglobe could get an offer

Ferroglobe saw its shares rise 8.5% following news reports from Reuters that a buyer might emerge for some of its hydroelectric power assets. Spanish infrastructure and construction company Ferrovial is reportedly looking at boosting its investment in renewable energy projects in its home country, which has made a commitment to move all of its electricity generation to renewable sources over the next 30 years. Ferroglobe apparently wasn't actively looking to sell the hydroelectric assets, but it has gotten expressions of interest from other parties even after regional regulators failed to approve a past offer for their sale. With its core markets under pressure, Ferroglobe might benefit from having a buyer take these noncore operations off its hands.

Check out the latest earnings call transcripts for Viacom, Ferroglobe, and Biogen.

Biogen gets a vote of confidence

Finally, shares of Biogen picked up 6%. The biotech giant came into the session having seen huge declines recently following bad news about its candidate treatment for Alzheimer's disease. Yet today, the stock climbed after Biogen got favorable comments from analysts at Piper Jaffray, who believe that the company is still worth a look from investors. In particular, the analysts thank that an experimental treatment for a form of lateral sclerosis could hold promise for future earnings. Even so, Piper has been in the minority, with many of its analyst peers downgrading the stock following the Alzheimer's-related setback.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool is short shares of CBS. The Motley Fool recommends Biogen. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Biogen Inc. Stock Quote
Biogen Inc.
$220.99 (1.27%) $2.77
Viacom, Inc. Stock Quote
Viacom, Inc.
Ferroglobe PLC Stock Quote
Ferroglobe PLC
$6.84 (3.01%) $0.20
Paramount Global Stock Quote
Paramount Global
$26.19 (1.51%) $0.39

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/15/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.